Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Bioresorbable Scaffolds: Lingering Challenges for a Device that Goes Away

Will noninferior results be good enough to win over cardiologists and payers?

Thumbnail

Inside the Cath Lab: Tracking Supplies, Cutting Costs

Cardinal Health

Balancing needs, utilization and cost while improving patient care are central to the mission of the interventional cardiology team at Emory Saint Joseph’s Hospital in Atlanta.

Thumbnail

Recovery Time: Despite Proven Benefits, Cardiac Rehabilitation Remains Underused

AACVPR is working to redefine how cardiac rehabilitation is referred, provided and reimbursed.

Thumbnail

Game Changer: Success Positions TAVR for Expanded Indications

Transcatheter aortic valve replacement (TAVR) is proving to be a disruptive technology, as cardiac surgeons and cardiologists join forces and combine resources to determine its ultimate utility.

Thumbnail

Data Drought: The Struggle to Build Evidence in Vascular Medicine & Intervention

How VIVA Physicians is working to answer questions about treatment of vascular disease.

Statin use does not reduce risk of acute kidney injury following cardiac surgery

Adults who received atorvastatin before, during and after cardiac surgery did not have a reduction in the risk of acute kidney injury compared with a placebo group, according to a double-blinded, placebo-controlled, randomized trial.

Abbott initiates voluntary MitraClip delivery system safety notice

Abbott initiated a voluntary safety notice on Feb. 26 regarding its MitraClip delivery system. Although the FDA classified the notice as a Class I recall, Abbott is not removing any products from commercial distribution.

Thumbnail

Women have lower one-year mortality rates after TAVR with the Sapien valve

Women undergoing transcatheter aortic valve replacement (TAVR) had a lower mortality rate one year after the procedure compared with men, according to a secondary analysis of the PARTNER (Placement of Aortic Transcatheter Valves) trial.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.